We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more
Live webcast on Wednesday, January 29th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the โCompanyโ or โSonnetโ) (NASDAQ: SONN), a...
SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters combination evaluation with trabectedin (Yondelisยฎ...
PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the โCompanyโ or โSonnetโ) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.24 | 15.4838709677 | 1.55 | 2.05 | 1.44 | 524649 | 1.84917045 | CS |
4 | 0.28 | 18.5430463576 | 1.51 | 2.52 | 1.44 | 332649 | 1.77232918 | CS |
12 | -2.72 | -60.310421286 | 4.51 | 10.02 | 1.41 | 1595330 | 2.48109034 | CS |
26 | -5.0988 | -74.0157937522 | 6.8888 | 10.02 | 1.41 | 766174 | 2.81761629 | CS |
52 | -9.09 | -83.5477941176 | 10.88 | 18.7192 | 1.41 | 422410 | 3.77456914 | CS |
156 | -770.1812 | -99.7681260648 | 771.9712 | 1649.4016 | 1.41 | 1918035 | 553.03042245 | CS |
260 | -15324.29 | -99.9883205621 | 15326.08 | 39916.8 | 1.41 | 2294815 | 2544.85975759 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions